29 Participants Needed

Cognitive Behavioral Therapy for Gastroparesis

HK
RK
Overseen ByRebecca Karlson
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 4 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial examines how Cognitive Behavioral Therapy (CBT), a type of talk therapy, can assist people with gastroparesis, a condition that slows or stops food movement through the stomach. Researchers aim to determine if CBT can alleviate symptoms like nausea and fullness, as well as related issues such as pain and anxiety. They will also analyze brain scans and other tests before and after therapy to understand its effects. Individuals who have experienced gastroparesis symptoms for at least 12 weeks and have internet access might be suitable for this trial. As an unphased trial, this study offers a unique opportunity to contribute to understanding how CBT can enhance life for those with gastroparesis.

Will I have to stop taking my current medications?

You can continue taking your current medications if they have been stable for at least 30 days before the study and you agree not to change them during the study. However, you cannot take psychotropic drugs, opioids, or illicit drugs.

What prior data suggests that Cognitive Behavioral Therapy is safe for treating gastroparesis?

Research has shown that Cognitive Behavioral Therapy (CBT) safely treats mental health issues. CBT helps individuals identify and change negative thought patterns. Studies have found it to be well-tolerated with minimal side effects. Most participants report a positive experience with CBT. By focusing on improving mental health without medication, it reduces the risk of adverse reactions. Overall, CBT is considered a safe choice for many.12345

Why are researchers excited about this trial?

Unlike the standard treatments for gastroparesis, which often involve medications to manage symptoms like nausea or dietary changes, Cognitive Behavioral Therapy (CBT) offers a unique approach by addressing the mental and emotional aspects of the condition. Researchers are excited about CBT because it uses a psychological method to potentially improve patients' quality of life through virtual sessions, making it more accessible and convenient. This therapy focuses on changing thought patterns related to the condition, which could lead to better management of symptoms without relying solely on medication.

What evidence suggests that Cognitive Behavioral Therapy is effective for gastroparesis?

Research has shown that Cognitive Behavioral Therapy (CBT), which participants in this trial will receive, can alleviate symptoms of gastroparesis. Studies have found that CBT reduces stomach-related symptoms and improves mental health by lowering depression and anxiety. One small study reported a significant decrease in the severity of gastroparesis symptoms and an enhanced overall quality of life. These findings suggest that CBT might be a useful non-drug option for managing gastroparesis and its related issues.678910

Who Is on the Research Team?

Braden Kuo, MD - Mass General Advances ...

Braden Kuo, MD

Principal Investigator

Massachusetts General Hospital

Are You a Good Fit for This Trial?

This trial is for adults aged 18-65 with gastroparesis, a condition causing delayed stomach emptying. Participants must have had symptoms for at least 12 weeks and not received CBT for chronic illness before. They need internet access, speak English, be on stable medication doses, and have specific BMI and gastric emptying study results. Exclusions include MRI contraindications like metal implants or claustrophobia, certain medications use, other conditions that could cause similar symptoms or inability to comply with the study.

Inclusion Criteria

I've been on the same medication dose for 30 days and won't change it during the study.
Body mass index (BMI) ≥ 17.5 kg/m2
Speak, write, and understand English
See 5 more

Exclusion Criteria

Inability to comply with or complete GES test
Use of narcotic analgesics greater than three days per week
Presence of conditions that could explain the patient's symptoms
See 9 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo an 8-week Cognitive Behavioral Therapy (CBT) trial with weekly sessions conducted via online videoconferencing

8 weeks
8 visits (virtual)

Post-Treatment Testing

Participants undergo post-treatment testing including brain MRI, autonomic function test (AFT), and nutrient drink test (NDT) to assess the impact of CBT

1 week

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments up to 12 weeks post-treatment

12 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Cognitive Behavioral Therapy
Trial Overview The trial tests Cognitive Behavioral Therapy's (CBT) effects on gastroparesis by assessing changes in brain-gut signaling. Patients will undergo pre- and post-CBT evaluations using brain MRI scans, autonomic function tests, gastric emptying studies among others to see if CBT can improve symptoms of pain, depression, anxiety related to their condition.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Cognitive Behavioral TherapyExperimental Treatment1 Intervention

Cognitive Behavioral Therapy is already approved in European Union, United States, Canada for the following indications:

🇪🇺
Approved in European Union as Cognitive Behavioral Therapy for:
🇺🇸
Approved in United States as Cognitive Behavioral Therapy for:
🇨🇦
Approved in Canada as Cognitive Behavioral Therapy for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Massachusetts General Hospital

Lead Sponsor

Trials
3,066
Recruited
13,430,000+

Published Research Related to This Trial

Dialectical behavior therapy (DBT) has been effectively adapted for various populations beyond its original use for parasuicidal women with borderline personality disorder, showing positive outcomes in settings such as outpatient care, inpatient treatment, and crisis intervention.
Outcome studies indicate that DBT is beneficial for a range of issues, including substance use disorders, suicidal behavior in adolescents, eating disorders, and even in correctional facilities, highlighting its versatility and effectiveness across different patient groups.
Dialectical behavior therapy: current status, recent developments, and future directions.Robins, CJ., Chapman, AL.[2022]
In a review of studies involving 2076 gastroparesis patients, it was found that 24% experienced combined anxiety and depression, with significant levels of psychological distress correlating with the severity of their symptoms.
Patients with gastroparesis reported a lower quality of life compared to population norms, and one study suggested that psychological interventions could improve both depression and gastric function, although this study had methodological limitations.
Psychological controversies in gastroparesis: A systematic review.Woodhouse, S., Hebbard, G., Knowles, SR.[2022]
Dialectical behavior therapy (DBT) is an effective, evidence-based treatment specifically designed for borderline personality disorder (BPD), particularly benefiting parasuicidal women, but also showing promise for those with substance use disorders and binge-eating disorder.
DBT incorporates unique elements such as a focus on emotions, a dialectical philosophy, and mindfulness techniques, which differentiate it from other cognitive-behavioral therapies and are essential for its effectiveness.
Dialectical behavior therapy: current indications and unique elements.Chapman, AL.[2021]

Citations

Improvement in Gastrointestinal Symptoms After Cognitive ...CBT improvement rates post treatment are among the highest in the IBS outcome literature when examined on an absolute level. To put these data in context, ...
Review article Cognitive behavioural therapy-based ...This review suggests promising evidence that CBT effectively improves gastrointestinal symptoms and psychological outcomes in patients with gastroduodenal ...
Central and Peripheral Effects of Cognitive Behavioral ...The purpose of this study is to examine the non-pharmacological impact of Cognitive Behavioral Therapy (CBT) on gastroparesis symptoms and other clinical co- ...
4.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/37832277/
Cognitive behavioural therapy-based interventions for ...This review suggests promising evidence that CBT effectively improves gastrointestinal symptoms and psychological outcomes in patients with gastroduodenal DGBIs
A Pilot Development Trial of Cognitive-Behavioral ...There were large decreases in gastroparesis symptom severity (r=.90) and improvements in both upper gastrointestinal-specific (r=.81) and general quality of ...
Behavioral Therapy - StatPearls - NCBI Bookshelf - NIHBehavioral therapy is a practical approach to modifying behavior using techniques such as reinforcement, enhanced communication, shaping, and modeling.
Five Different Approaches to TherapyDBT balances the acceptance of ourselves where we are, while also changing what we want to change to build the life we want to be living.
Understanding Therapy Names: CBT, DBT, ACT, and MoreDialectical behavior therapy (DBT) is a type of therapy that teaches teens and young adults how to handle strong emotions and stressful situations. It includes ...
The 8 Types of Cognitive Behavior TherapyCognitive Therapy is one of the earliest therapies to be considered CBT. It focuses on identifying and changing the unhelpful or distorted thinking patterns ...
Cognitive Behavioral Therapy: Techniques, Types, and UsesCognitive behavioral therapy (CBT) is a treatment approach that helps you recognize negative or unhelpful thought and behavior patterns.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security